![Tomasz P. Stryjewski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tomasz P. Stryjewski
Fundador en Pykus Therapeutics, Inc. .
Cargos activos de Tomasz P. Stryjewski
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Pykus Therapeutics, Inc.
![]() Pykus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Pykus Therapeutics, Inc. engages in the development of a dissolvable intraocular surgical device. It offers novel polymer that provides retinal tamponade. The company was founded by James Stefater and Tomasz Stryjewski and is headquartered in Boston, MA. | Fundador | 01/01/2016 | - |
Historial de carrera de Tomasz P. Stryjewski
Antiguos cargos conocidos de Tomasz P. Stryjewski.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Helio Vision, Inc.
![]() Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | Fundador | 01/01/2016 | - |
Estadísticas
Internacional
Estados Unidos | 3 |
Operativa
Founder | 2 |
Sectorial
Health Technology | 2 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Helio Vision, Inc.
![]() Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | Health Technology |
Pykus Therapeutics, Inc.
![]() Pykus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Pykus Therapeutics, Inc. engages in the development of a dissolvable intraocular surgical device. It offers novel polymer that provides retinal tamponade. The company was founded by James Stefater and Tomasz Stryjewski and is headquartered in Boston, MA. | Commercial Services |
- Bolsa de valores
- Insiders
- Tomasz P. Stryjewski
- Experiencia